Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - PMC
The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide the mRNA ...
www.ncbi.nlm.nih.gov
We believe a comprehensive risk/benefit assessment of the mRNA vaccines questions them as positive contributors to public health.
